Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.62 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.53 |
| ▸ | F10 | P00742 | 8/20 | 0.51 |
| ▸ | F2 | P00734 | 6/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.51 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.51 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.45 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.44 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30261671 | 0.87 | OPRM1 (0.53) | OPRM1HSD17B14F10F2PRSS1 | |
| SCHEMBL7110101 | 0.86 | KDM4E (0.57) | OPRM1HSD17B14F10F2PRSS1 | |
| SCHEMBL28252043 | 0.83 | HSD17B14 (0.53) | OPRM1HSD17B14F10F2PRSS1 | |
| SCHEMBL23188985 | 0.83 | HSD17B14 (0.53) | OPRM1HSD17B14F10F2PRSS1 | |
| SCHEMBL28748015 | 0.82 | OPRM1 (0.65) | OPRM1F10F2PRSS1PRSS2 | |
| SCHEMBL8068188 | 0.82 | P2RX7 (0.53) | OPRM1HSD17B14F10F2PRSS1 | |
| SCHEMBL3697994 | 0.82 | OPRM1 (0.61) | OPRM1F10F2PRSS1PRSS2 | |
| SCHEMBL3696055 | 0.81 | OPRM1 (0.67) | OPRM1F10F2PRSS1PRSS2 | |
| SCHEMBL8498266 | 0.80 | F10 (0.48) | OPRM1HSD17B14F10F2PARP10 | |
| SCHEMBL7608437 | 0.80 | MAPT (0.67) | OPRM1HSD17B14MAPTP2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4749647-B2 | — | — | 2011-08-17 | — | — | JP | claimed |
| EP-1464223-B1 | Synergistic herbicidal mixtures | BASF AG (DE) | 2006-08-23 | — | — | EP | claimed |
| EP-1267612-B1 | SYNERGISTIC HERBICIDAL MIXTURES | BASF AG (DE) | 2004-11-03 | — | — | EP | claimed |
| EP-1464223-A1 | Synergistic herbicidal mixtures | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-06 | — | — | EP | claimed |
| US-6645911-B2 | Using a 6-phenoxypyridyl-2-yl carboxamide compound | BASF AKTIENGESELLSCHAFT (DE) | 2003-11-11 | — | — | US | claimed |
| JP-2003528893-A | — | — | 2003-09-30 | — | — | JP | claimed |
| EP-1267612-A1 | SYNERGISTIC HERBICIDAL MIXTURES | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-02 | — | — | EP | claimed |
| US-20020028747-A1 | Synergistic herbicidal mixtures | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-07 | — | — | US | claimed |
| WO-2001074157-A2 | SYNERGISTIC HERBICIDAL MIXTURES | BASF AG (DE) | 2001-10-11 | — | — | WO | claimed |
| CN-119528914-A | Benzazepine ketone derivative and application thereof | 杭州百诚医药科技股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-3342771-B1 | HETEROCYCLIC AMIDES AS KINASE INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2020-11-25 | — | — | EP | disclosed |
| EP-3375780-B1 | HETEROCYCLIC AMIDES AS KINASE INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2020-06-03 | — | — | EP | disclosed |
| EP-3508484-A1 | HETEROCYCLIC AMIDES AS KINASE INHIBITORS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2019-07-10 | — | — | EP | disclosed |
| EP-3342771-A1 | HETEROCYCLIC AMIDES AS KINASE INHIBITORS | GlaxoSmithKline Intellectual Property Development Ltd (GB) | 2018-07-04 | — | — | EP | disclosed |
| WO-1999024427-A1 | HERBICIDAL FURANYL- AND THIENYLOXYAZINES | AMERICAN CYANAMID COMPANY (US) | 1999-05-20 | — | — | WO | disclosed |
| US-5869426-A | Herbicidal 6-thienyloxypyrid-2-carboxamides | AMERICAN CYANAMID COMPANY (US) | 1999-02-09 | — | — | US | disclosed |
| US-5707932-A | PLANT GROWTH REGULATORS; PRE- AND POSTEMERGENCE | AMERICAN CYANAMID COMPANY (US) | 1998-01-13 | — | — | US | disclosed |
| EP-0665841-B1 | HERBICIDAL PYRAZOLYLOXY-PICOLINAMIDES | SHELL INT RESEARCH (NL) | 1996-07-17 | — | — | EP | disclosed |
| US-5384305-A | Plant growth regulators | SHELL RESEARCH LIMITED (GB) | 1995-01-24 | — | — | US | disclosed |
| EP-0488474-A1 | Herbicidal carboxamide derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1992-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028747-A1 | Synergistic herbicidal mixtures | CACNA1F, THRA, CA5A | OPRM1 1843/4885HSD17B14 2763/4885F10 4493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.